Insilico Opens AI Toolkit for Global Longevity Research
Abu Dhabi, UAE, September 17, 2026 Insilico Medicine has announced the global opening of its AI-powered longevity discovery toolkit,...
cGxPwire Editor
Advertisement
Inductive Bio Launches Beacon-2 for AI Drug Discovery
New York, New York, September 17, 2026 Inductive Bio has launched Beacon-2, a new artificial intelligence system designed to...
Aethlon Medical Merges With North Immunology for NOR-101
San Diego, California, and Austin, Texas, September 17, 2026 Aethlon Medical, Inc. and North Immunology, Inc. have announced a...
Insilico Medicine Advances AI-Designed BTK Cancer Drugs
Abu Dhabi, UAE, September 17, 2026 Insilico Medicine has announced a new milestone from its UAE-based AI drug discovery...
DarioHealth Expands AI Care to 1.5 Million Lives
New York, New York, September 17, 2026 DarioHealth Corp. has announced a new contract with one of New Jersey’s...
Advertisements
Nuvation Bio IBTROZI Label Updated With Long-Term Data
New York, New York, September 17, 2026 Nuvation Bio Inc. has announced that the U.S. Food and Drug Administration...
Novo Nordisk Denecimig Shows Tolerability in Hemophilia A
Plainsboro, New Jersey, and Bagsværd, Denmark, September 17, 2026 Novo Nordisk has announced published Phase 3b results from the...
Akeso AK158D1 Gets NMPA Phase I Clearance for Tumors
Hong Kong, September 17, 2026 Akeso, Inc. has announced that its investigational AK158D1, a next-generation EGFR/TROP2 bispecific antibody-drug conjugate...
Roche Lunsumio Regimen Improves PFS in Follicular Lymphoma
Basel, Switzerland, September 17, 2026 Roche has announced positive results from the Phase III CELESTIMO study, showing that a...
Bayer Kerendia Wins FDA Approval for Type 1 Diabetes CKD
Berlin, Germany, September 17, 2026 Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Kerendia™ (finerenone)...
Advertisement
